Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Liechtenstein.
Press releases published on June 19, 2025

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from …

Premier Health Announces a Strategic Review Process to Enhance Shareholder Value
MONTRÉAL, June 19, 2025 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Company” or “Premier Health”), a leading Canadian health tech company, today announced that its Board of Directors (the “Board”) has initiated a formal strategic …

Expanding Access in California: SmartVascular Dx™ Test Now Available Through Major Health Plans
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- MorningStar Laboratories, LLC., (“MSL” or “the Company”), a leading developer of precision diagnostic tests that address unmet clinical needs, is excited to announce that the SmartVascular Dx™ test ( …

The Ensign Group, Inc. Declares Quarterly Dividend of $0.0625 Per Share
SAN JUAN CAPISTRANO, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living services, physical, occupational and …

Labviva Showcases Advanced AI Procurement Tools at the R&D Procurement and Sourcing in Pharma Summit 2025
BOSTON, June 19, 2025 (GLOBE NEWSWIRE) -- Labviva, the leading AI procurement platform for life sciences, today announced its plans to demonstrate how pharmaceutical and biotech companies can leverage AI for laboratory procurement to drive cost and …

CD5 Targeted Therapies CD5 Targeting CAR T Cell Therapy Clinical Trials Market Insight 2025
Delhi, June 19, 2025 (GLOBE NEWSWIRE) -- Global CD5 Targeting Therapies Market Trends, Clinical Trials, Technology Platforms …

Global Protein Expression Market to Observe Growth at a CAGR of ~8% by 2032 | DelveInsight
New York, USA, June 19, 2025 (GLOBE NEWSWIRE) -- Global Protein Expression Market to Observe Growth at a CAGR of ~8% by 2032 | DelveInsight The protein expression market is primarily driven by the increasing prevalence of chronic diseases, which in turn …

Urea Cycle Disorders Market to Register Sustainable Growth During the Study Period (2020–2034) | DelveInsight
New York, USA, June 19, 2025 (GLOBE NEWSWIRE) -- Urea Cycle Disorders Market to Register Sustainable Growth During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the growth of the urea cycle disorders market is expected …

Dermatomyositis Market Set to Witness Significant Growth During the Study Period (2020–2034) Amid Rising Awareness and Advanced Treatments | DelveInsight
New York, USA, June 19, 2025 (GLOBE NEWSWIRE) -- Dermatomyositis Market Set to Witness Significant Growth During the Study Period (2020–2034) Amid Rising Awareness and Advanced Treatments | DelveInsight The dermatomyositis market is expected to witness …

Unyte Health Launches Sonocea® Enhanced Rest and Restore Protocol™: Revolutionary Approach for Nervous System Regulation
DENVER, June 19, 2025 (GLOBE NEWSWIRE) -- Unyte Health, a leader in nervous system health technology and sound-based interventions, is proud to announce the launch of the Sonocea® Enhanced Rest and Restore Protocol™ (RRP), a revolutionary healing …

Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment
BRIDGEWATER, N.J. and NETANYA, Israel, June 19, 2025 (GLOBE NEWSWIRE) -- Theranica, a pioneer in drug-free neuromodulation treatments for idiopathic pain conditions, today announced the presentation of three new real-world studies at the 2025 American …

Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress
PRESS RELEASE Memo Therapeutics AG to Present Interim Phase II Results of Potravitug for the Treatment of BKV Infection in Kidney Transplant Recipients in a Late Breaking Oral Presentation at the World Transplant Congress Schlieren / Zurich, Switzerland, …

Castle Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
FRIENDSWOOD, Texas, June 19, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that on June 14, 2025, the Compensation Committee of its Board of …

dGenThera and Nusano Sign Letter of Intent for Astatine‑211 Supply
DURHAM, N.C. and WEST VALLEY CITY, Utah, June 19, 2025 (GLOBE NEWSWIRE) -- dGenThera, Inc., a biotechnology company pioneering theranostic molecular pairs, and Nusano, a physics company transforming the production of radioisotopes, today announced the …

Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott’s Future Dual Glucose-Ketone Sensor
IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet Bionic Pancreas automated insulin delivery (AID) system …

VitalHub Completes Acquisition of Induction
TORONTO, June 19, 2025 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) announced that it has completed the cash acquisition of Induction Healthcare Group PLC (“Induction”) by way of a court-sanctioned scheme of …

Annovis Announces NYSE Acceptance of Plan to Regain Listing Compliance
MALVERN, Pa., June 19, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and …

CrazyBulk “Legal Steroid Alternatives” for Muscle Growth: A Safer Shift in Bodybuilding and Performance Nutrition 2025
New York City, NY, June 19, 2025 (GLOBE NEWSWIRE) -- As traditional anabolic steroids fall further out of favor due to health and legal concerns, the CrazyBulk line of natural performance supplements emerges as a widely discussed alternative—designed to …

Catholic Health Teams Up with Olympic Gold Medalist Katie Ledecky to Help Patients Optimize Their Health
ROCKVILLE CENTRE, N.Y., June 19, 2025 (GLOBE NEWSWIRE) -- Catholic Health is teaming up with nine-time Olympic gold medalist and 21-time world champion swimmer Katie Ledecky to launch a new public education campaign: Optimizing Your Health for Greater …

Verano Announces Exclusive Partnership with Award-Winning Arizona Cannabis Operator Grow Sciences to Bring its Best-In-Class Products to Illinois
Grow Sciences flower, pre-rolls, solventless extracts, vaporizers and edibles will initially be sold exclusively at Zen Leaf dispensaries in the Illinois market CHICAGO, June 19, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) …